This is Gafo

Papua New Guinea’s first polio case in decades is a champion for eradication

Gafo is the first case of polio in Papua New Guinea in almost two decades. WHO PNG/J.Rivaca

For six-year old Gafo that fateful April 2018 morning was supposed to be the start of just another day full of running around and playing with friends. Ignoring the pain in his legs, Gafo tried to get out of bed, but he fell and struggled to get back up. Over the course of the next two days, Gafo’s condition continued to deteriorate. On the third day, Gafo and his family visited the Angau Memorial General Hospital in Lae, Morobe, in the central northern coast of Papua New Guinea, only to find out that he had polio.

As soon as Gafo’s story broke, a National Emergency was declared by the Government and a mass polio vaccination campaign was initiated. Gafo became the foremost champion of polio awareness, and served as a cautionary tale for families and young children to get vaccinated.

Since his diagnosis, Gafo has made progress. Though he can now walk with his signature gait, Gafo and his parents understand that polio is irreversible, but is preventable and eradicable. Gafo hopes to become a doctor one day. Read about his entire journey from being an ordinary child to breaking news, and how his story has helped contain polio in Papua New Guinea.

This story is originally from the Papua New Guinea Polio Outbreak Response First 100 Days report.


Related News

   19/10/2021
For a few incredible eradicators, a life’s purpose doesn’t stop at retirement
   10/10/2021
The recommendation further advances nOPV2 as a critical new tool in the fight against circulating vaccine-derived poliovirus type 2 (cVDPV2)
   08/02/2021
Report outlines the vital role that the polio eradication network plays in global health security and argues that this infrastructure must be sustained.
   02/02/2021
Dr. De Sousa has spent more than twenty years charting the highs and lows of polio eradication in Angola.
   13/11/2020
Nouvel outil à utiliser pour lutter contre le PVDVc2
   13/11/2020
WHO has issued an Emergency Use Listing recommendation for the type 2 novel oral polio vaccine (nOPV2)